- Home
- CPBI vs CNTX Comparison
CPBI vs CNTX Comparison
Compare CPBI & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- CNTX
- Stock Information
- Founded
- CPBI 2023
- CNTX 2015
- Country
- CPBI United States
- CNTX United States
- Employees
- CPBI N/A
- CNTX N/A
- Industry
- CPBI
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- CNTX Health Care
- Exchange
- CPBI Nasdaq
- CNTX Nasdaq
- Market Cap
- CPBI 56.2M
- CNTX 60.7M
- IPO Year
- CPBI N/A
- CNTX 2021
- Fundamental
- Price
- CPBI $15.00
- CNTX $0.84
- Analyst Decision
- CPBI
- CNTX Strong Buy
- Analyst Count
- CPBI 0
- CNTX 5
- Target Price
- CPBI N/A
- CNTX $6.50
- AVG Volume (30 Days)
- CPBI 9.6K
- CNTX 63.4K
- Earning Date
- CPBI 01-01-0001
- CNTX 03-20-2025
- Dividend Yield
- CPBI N/A
- CNTX N/A
- EPS Growth
- CPBI 29.70
- CNTX N/A
- EPS
- CPBI 1.62
- CNTX N/A
- Revenue
- CPBI $18,546,000.00
- CNTX N/A
- Revenue This Year
- CPBI N/A
- CNTX N/A
- Revenue Next Year
- CPBI N/A
- CNTX N/A
- P/E Ratio
- CPBI $9.11
- CNTX N/A
- Revenue Growth
- CPBI 13.73
- CNTX N/A
- 52 Week Low
- CPBI $9.96
- CNTX $0.64
- 52 Week High
- CPBI $15.50
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- CPBI 63.67
- CNTX 51.10
- Support Level
- CPBI $14.80
- CNTX $0.64
- Resistance Level
- CPBI $14.81
- CNTX $0.87
- Average True Range (ATR)
- CPBI 0.08
- CNTX 0.08
- MACD
- CPBI 0.02
- CNTX 0.01
- Stochastic Oscillator
- CPBI 100.00
- CNTX 69.23
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.